三七互娛(002555.SZ)高開4.99% 定增獲睿遠等明星機構捧場
格隆匯3月8日丨三七互娛(002555.SZ)跳空高開4.99%報31.32元,盤前成交6038萬元,最新市值695億元。公司昨日公佈定增結果,定增計劃獲多家機構參與,最終確認獲配對象為14個,募集資金總額約29.33億元。其中睿遠基金、交銀施羅德基金和正心谷分別認購7.02億元、5.70億元5億元。此次發行價格為27.77元/股,較上週五的收盤價折價不到7%。據悉,三七互娛定增募集資金扣除發行費用後,擬用於網絡遊戲開發及運營建設項目、5G雲遊戲平台建設項目和廣州總部大樓建設項目。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.